FDA issues warning over Hepatitis C drug
Army Times
By Patricia Kime
Staff writer
Posted : Thursday Dec 20, 2012
The Food and Drug Administration is warning patients receiving treatment for hepatitis C with a triple drug regimen using Incevik, or telepriver, to be aware of a potentially dangerous, even fatal skin reaction.
The FDA on Wednesday announced it has altered Incevik’s label to include stronger warnings after some patients died from complications after developing a serious rash while taking Incevik along with two other medications for hepatitis C.
More than 2,700 active duty service members were diagnosed with chronic hepatitis C between 2000 and 2010, according to Pentagon data.
The Veterans Health Administration system has 170,000 patients with chronic hepatitis C, and more than 4,800 VA patients are receiving some kind of combination drug therapy for Hepatitis C.
read more here
No comments:
Post a Comment
If it is not helpful, do not be hurtful. Spam removed so do not try putting up free ad.